drugset / Trial / NCT06897228
PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
A single-center, single-arm, dose-escalation exploratory clinical trial on the safety and efficacy of PANK-003 cell injection(Peripheral blood-derived allogeneic natural killer cells )combined with standard adjuvant chemotherapy after surgery in patients with solid tumors
Timeline
- Start
- 2024-02-18
- Primary completion
- 2027-01
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PANK-003 | Cell therapy | — | — |
Indications
No indication recorded.